Found 37 matching trials
Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) PHASE2 This is a phase II study designed to evaluate the toxicity and efficacy of ...
Show More Location
Universitaetsklinikum Aachen
Learn More & Join Trial
Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma PHASE2 The purpose of this research is to see if Loncastuximab Tesirine in combina...
Show More Location
Florida Cancer Specialists and Research Institute
Learn More & Join Trial
Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Acute Lymphoblastic Leukemia (B-ALL) PHASE1 This study evaluates ADCT-402 in participants with relapsed or refractory B...
Show More Location
UC San Diego Moores Cancer Center
Learn More & Join Trial
Trial of Loncastuximab Tesirine in High Risk Diffuse Large B-cell Lymphoma Post Transplant PHASE2 Study of loncastuximab tesirine administered intravenously (IV) for mainten...
Show More Location
Barbara Ann Karmanos Cancer Institute
Learn More & Join Trial
Consolidation With Loncastuximab Tesirine After a Short Course of Immunochemotherapy in BTKi-treated (or Intolerant) Relapsed/Refractory Mantle Cell Lymphoma Patients. PHASE2 This is a prospective, phase 2, multicenter, open-label, single-arm study. ...
Show More Status
Active Not Recruiting
Location
ASST Spedali Civili di Brescia
Learn More & Join Trial
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post-transplant Lymphoproliferative Disorder (PLUTO) PHASE1 The purpose of phase I of this clinical trial is to learn the recommended d...
Show More Location
Huntsman Cancer Institute at University of Utah
Learn More & Join Trial
Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL) PHASE1 This study evaluates ADCT-402 in participants with Relapsed or Refractory B...
Show More Location
UC San Diego Moores Cancer Center
Learn More & Join Trial
Evaluation of Reporting of Antibody-Drug Conjugate Associated Sepsis-related Toxicities N/A Although antibody-drug conjugate(ADC) has proved effective in treating many...
Show More Location
Central South University
Learn More & Join Trial
A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma PHASE2 The Glo-BNHL trial is trying to find better medicines for children and youn...
Show More Location
The Children's Hospital at Westmead
Learn More & Join Trial
Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma PHASE2 The purpose of this Phase 2 study is to evaluate the clinical efficacy and ...
Show More Location
City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
Learn More & Join Trial